Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (Cedars-Sinai Medical Center)

N/A

Report date: 2022/12/30 14:54:02

Base Information

Drug NameHuman Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (Cedars-Sinai Medical Center)
Drug Alias Name人神经祖细胞-Cedars-Sinai Medical CenterCNS10-NPC-GDNFhNPC-CNS10-GDNF
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Neural progenitor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCedars-Sinai Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCedars-Sinai Medical Center
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A